首页> 外文期刊>Molecular cancer research: MCR >G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.
【24h】

G-quadruplex stabilizer 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide induces accelerated senescence and inhibits tumorigenic properties in cancer cells.

机译:G-四链体稳定剂3,6-双(1-甲基-4-乙烯基吡啶)咔唑二碘化物诱导加速衰老并抑制癌细胞的致癌特性。

获取原文
获取原文并翻译 | 示例
           

摘要

Carbazole derivatives that stabilized G-quadruplex DNA structure formed by human telomeric sequence have been designed and synthesized. Among them, 3,6-bis(1-methyl-4-vinylpyridinium)carbazole diiodide (BMVC) showed an increase in G-quadruplex melting temperature by 13 degrees C and has a potent inhibitory effect on telomerase activity. Treatment of H1299 cancer cells with 0.5 mumol/L BMVC did not cause acute toxicity and affect DNA replication; however, the BMVC-treated cells ceased to divide after a lag period. Hallmarks of senescence, including morphologic changes, detection of senescence-associated beta-galactosidase activity, and decreased bromodeoxyuridine incorporation, were detected in BMVC-treated cancer cells. The BMVC-induced senescence phenotype is accompanied by progressive telomere shortening and detection of the DNA damage foci, indicating that BMVC caused telomere uncapping after long-term treatments. Unlike other telomerase inhibitors, the BMVC-treated cancer cells showed a fast telomere shortening rate and a lag period of growth before entering senescence. Interestingly, BMVC also suppressed the tumor-related properties of cancer cells, including cell migration, colony-forming ability, and anchorage-independent growth, indicating that the cellular effects of BMVC were not limited to telomeres. Consistent with the observations from cellular experiments, the tumorigenic potential of cancer cells was also reduced in mouse xenografts after BMVC treatments. Thus, BMVC repressed tumor progression through both telomere-dependent and telomere-independent pathways. (Mol Cancer Res 2008;6(6):955-64).
机译:设计并合成了稳定由人端粒序列形成的G-四链体DNA结构的咔唑衍生物。其中,3,6-双(1-甲基-4-乙烯基吡啶鎓)咔唑二碘化物(BMVC)显示G-四链体的熔融温度升高了13摄氏度,并且对端粒酶活性具有有效的抑制作用。 0.5μmol/ L BMVC处理H1299癌细胞不会引起急性毒性,也不会影响DNA复制。然而,经过BMVC处理的细胞在滞后期后不再分裂。在BMVC处理的癌细胞中检测到了衰老的标志,包括形态变化,衰老相关的β-半乳糖苷酶活性的检测以及溴脱氧尿苷掺入的减少。 BMVC诱导的衰老表型伴随着渐进的端粒缩短和DNA损伤灶的检测,表明BMVC在长期治疗后引起端粒解封。与其他端粒酶抑制剂不同,经BMVC处理的癌细胞在进入衰老之前显示出快速的端粒缩短速率和生长的滞后期。有趣的是,BMVC还抑制了癌细胞的肿瘤相关特性,包括细胞迁移,集落形成能力和锚定非依赖性生长,这表明BMVC的细胞作用不仅限于端粒。与来自细胞实验的观察结果一致,BMVC处理后的小鼠异种移植物中癌细胞的致瘤潜力也降低了。因此,BMVC通过端粒依赖性和端粒依赖性途径抑制肿瘤进展。 (Mol Cancer Res 2008; 6(6):955-64)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号